RE: Barbershop15 Jun 2021 13:12
CDX - Is on a clock, Hemo are in-licencing from GlobalCo, the structure of that licencing agreement will detail GlobalCo's ongoing commitment and will likely make it clear what they get out of it at the end, IE first refusal or may even include a figure what they are willing to pay IF its successful at clinical trials. This could come any time, they started negotiating with GlobalCo in January, Hemo officially took the option to licence in April, we are now in June....
CAR-T - They have contracted someone to organise the raw materials for clinical trials and to draw up the IND application including clinical trial plain. This started months ago, he is a contractor, sooner he gets finished the sooner he gets paid, this could happen any time. Likely to be an IND application next.
CBR / Stealth Project - We have had name drops from another company, alot of excitement from everyone but there is no protection in place so there is zero detailed updates on this likely until its ready. Its part of the defence against disease-x so it could very well have government or defence connections, we just do not know what is going on here or when we will hear.
Hu-PHEC - In talks with various parties RE the cell bank, could come tomorrow, could be end of the year, we dont know.
J&J Collaboration - awaiting news on new agreement here, could be licencing agreement, no idea could take days/weeks/months.
Eli Lilly Lupus update - No updates in ages, big pharma move slow, update could come tomorrow, weeks, months.
Rock bottom prices also make for big opportunities for whale investors who can swoop in and harvest up the shares, while not "news" or linked to the science if this happens or has been happening, yet again you see a serious boost to investor confidence.
When is news coming? No idea, could be today, could be next week, could be after the AGM. Bottom line is the company is an absolute gift at this price, do your own research, there is plenty available to read.